See also this year's filing and all EDGAR filings for this company.
PDF Report 0001516551_2017_Skye_Bioscience_Inc.pdf
Logs
| warning | Missing logo | subcommand.report | {} |
Graph
Absolute values for 0001516551, Skye Bioscience Inc
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 279,489 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 0 |
| 2 | PropertyPlantAndEquipmentNet | 9,584 |
| 3 | remainder_Assets | 34,290 |
| 4 | LiabilitiesCurrent | 661,958 |
| 5 | LiabilitiesNoncurrent | 1,112,308 |
| 6 | remainder_Liabilities | 0 |
| 7 | CostOfGoodsAndServicesSold | 0 |
| 8 | SellingGeneralAndAdministrativeExpense | 3,406,704 |
| 9 | ResearchAndDevelopmentExpense | 2,753,774 |
| 10 | remainder_Expenses | -5,646,836 |
| 11 | remainder_Revenues | 0 |
| 12 | remainder_NetIncome | 0 |
| 13 | remainder_ComprehensiveNetIncome | 0 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 323,363 |
| 1 | Liabilities | 1,774,266 |
| 2 | Expenses | 513,642 |
| 3 | Revenues | 0 |
| 4 | StockholdersEquity | -1,450,903 |
| 5 | NetIncome | -513,642 |
| 6 | ComprehensiveNetIncome | -513,642 |
| 7 | BaseVar | 1,305,636 |
| 8 | EconomicCapitalRatiobeforeLimitedLiability | -3.51 |
| 9 | EconomicCapitalRatio | 0.528 |